In Brief: Cardiac Pacemakers' Endotak
This article was originally published in The Gray Sheet
Cardiac Pacemakers' Endotak: Guidant subsidiary launches Endotak Model 115 single lead defibrillation system to U.S. market. The Model 115 is 70 cm in length, shorter than currently offered CPI leads, which are 100 cm. One potential use for the short lead is with pectorally implanted automatic implantable cardioverter defibrillator products. A premarket approval application supplement for Guidant's Ventak PRx III AICD, which can be implanted pectorally, was approved by FDA in early May ("The Gray Sheet" May 8, In Brief)...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.